Spironolactone Tablet, Film Coated
Product Images NDC 76420-062

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Spironolactone (NDC 76420-062). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Asclemed Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (Spironolactone 25mg Label)

Packaging label for Spironolactone Tablets USP 25 mg, film coated tablets in a quantity of 30. The label includes the NDC number 76420-062-30 and states it is manufactured for Accord Healthcare, Inc. The label lists the distributor as Enovachem Pharmaceuticals with an address in Torrance, CA.*

FDA Label Image

Principal Display Panel (Spironolactone 50mg Label)

Label for Spironolactone Tablets, USP 50 mg, film-coated tablets packaged by Enovachem Pharmaceuticals. The label indicates NDC 76420-063-30, with a quantity of 30 tablets. It includes storage instructions, prescription status, and a caution statement about federal law prohibiting dispensing without a prescription.*

FDA Label Image

Figure 1 (Spironolactone Figure 1)

A line graph showing probability over time in months for two groups: Spironolactone (n=822) and Placebo (n=841). The graph depicts a higher probability over time for the Spironolactone group compared to Placebo, with a log-rank p-value less than 0.001, indicating a significant difference between the groups.*

FDA Label Image

Figure 2 (Spironolactone Figure 2)

A forest plot showing hazard ratios (HR) with 95% confidence intervals (CI) for various subgroups comparing spironolactone to placebo. Subgroups include age, sex, race, LVEF, heart failure type, NYHA class, diabetes status, serum creatinine, creatinine clearance, potassium levels, digoxin use, ACE inhibitor use, and beta blocker use. The plot visually indicates where spironolactone is favored versus placebo.*

FDA Label Image

Chemical Structure (Spironolactone Structure Image)

Chemical structure diagram of spironolactone, showing its steroid-derived fused ring system with various functional groups including a lactone ring and a thioacetyl side chain.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.